Tata Chemicals Q1 FY27 Results: Revenue Rs 4,255 Cr, Consolidated Profit Rs 60 Cr
Tata Chemicals reported Q1 FY27 results. Consolidated revenue rose to ₹4,255 crore from ₹3,719 crore YoY. Consolidated profit after tax was ₹60 crore, down from ₹316 crore. Standalone revenue increased to ₹1,281 crore from ₹1,169 crore, with profit after tax at ₹343 crore, up from ₹307 crore. The results were approved on July 27, 2026.
The results show a mixed performance with an increase in revenue but a decrease in consolidated profit. This might lead to a moderate investor reaction as they assess the reasons behind the profit decline.
While revenue showed an increase, the consolidated profit saw a significant decline, indicating a mixed financial performance. The standalone results were positive, but the consolidated figures present a less optimistic picture.
Tata Chemicals Limited announced its unaudited consolidated and audited standalone financial results for the quarter ended June 30, 2026. The Board of Directors approved these results at a meeting held on July 27, 2026.
Consolidated revenue from operations for the quarter stood at ₹4,255 crore, a notable increase from ₹3,719 crore in the same quarter last year. However, the consolidated profit after tax for the quarter was ₹60 crore, a decrease compared to ₹316 crore in the corresponding quarter of the previous year. The consolidated loss before tax was ₹110 crore.
On a standalone basis, revenue from operations for the quarter was ₹1,281 crore, up from ₹1,169 crore in the prior year's quarter. The standalone profit after tax for the quarter was ₹343 crore, an increase from ₹307 crore in the same period last year. The standalone profit before tax was ₹392 crore.
These financial results were published in the Business Standard (English), The Free Press Journal (English), and Navshakti (Marathi) newspapers on July 28, 2026. A copy of the published results is also available on the company's website, www.tatachemicals.com.
What to do with a filing like this
Tata Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tata Chemicals Limited. Read the original for the full detail.